| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2006 | WO2005079195A3 Pyrazolopyridines and analogs thereof |
| 08/10/2006 | WO2005077048A3 Immune modulation by regulating expression of the “minor” gene in immune dendritic cells |
| 08/10/2006 | WO2005062782A3 Non-animal product containing veterinary formulations |
| 08/10/2006 | WO2005055956A3 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 08/10/2006 | WO2005041997A8 Methods and compositions comprising ilex |
| 08/10/2006 | WO2005041856A3 Use of 2-thia-dibenzo[e, h]azulenes for the treatment and prevention of central nervous system diseases and disorders |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | WO2005023189A3 Method of cox-2 selective inhibitor and nitric oxide-donating agent |
| 08/10/2006 | WO2005017101A3 Avian adenoassociated virus (aaav) and uses thereof |
| 08/10/2006 | WO2004105694A3 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 08/10/2006 | WO2004050894A3 Heart failure gene determination and therapeutic screening |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178518 3'-[(2z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hy-drazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 08/10/2006 | US20060178516 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 08/10/2006 | US20060178514 Novel benzylamine derivatives as CETP inhibitors |
| 08/10/2006 | US20060178439 Crystalline form of zoledronic acid |
| 08/10/2006 | US20060178438 Muscarinic agonists |
| 08/10/2006 | US20060178437 Such as systemic lupus erythematosus by administering suberoylanilide hydroxamic acid; histone deacetylase inhibitors |
| 08/10/2006 | US20060178436 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 08/10/2006 | US20060178435 Apogossypolone and the uses thereof |
| 08/10/2006 | US20060178434 Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes |
| 08/10/2006 | US20060178433 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto |
| 08/10/2006 | US20060178432 Dyslipidemias, diabetes; (2S)-2-ethoxy-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid |
| 08/10/2006 | US20060178430 Synthetic analogs of naturally occurring and non-naturally occurring acyl-homoserine lactone (AHL) analogs; N-butanoyl-L-homoserine lactone |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178428 7-Carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 08/10/2006 | US20060178427 chemically linking the taxane to a cell binding agent such as monoclonal antibody for tumor antigen; taxane has extra ether bridge group, and chemical group for conjugation such as mercapto |
| 08/10/2006 | US20060178426 Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome |
| 08/10/2006 | US20060178424 Preventing atrial fibrillation (af) with the use of stain drugs |
| 08/10/2006 | US20060178423 Administer amino acid precursor L-dopa, tyrosine, D,L-Phenylalanine, and N-acetyl-L-tyrosine; serotonin precursor of 5-HTP and tryptophan; and cofactors of vitamin B6, Vitamin C, Calcium, Folate, Cysteine; minimal side effects at higher doses, one precursor balances the other |
| 08/10/2006 | US20060178422 Process for making (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl] amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid |
| 08/10/2006 | US20060178421 Hydrogenation catalysts |
| 08/10/2006 | US20060178420 Indole derivatives as anti-inflammatory agents |
| 08/10/2006 | US20060178419 3-Sulfonylamino-pyrrolindine -2- one derivatives as inhibitors of factor xa |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178417 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives |
| 08/10/2006 | US20060178415 Azole derivatives as antifungal agents |
| 08/10/2006 | US20060178414 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 08/10/2006 | US20060178413 Diphenylurea derivatives and their use as chloride channel blockers |
| 08/10/2006 | US20060178412 [3-(Benzo[b]thiophene-2-carbonyl)-5-(4-methyl phenyl)-1H-indol-1-yl]-acetic acid, for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis, coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 08/10/2006 | US20060178411 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178407 Substituted pyridines and their uses |
| 08/10/2006 | US20060178406 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
| 08/10/2006 | US20060178405 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178402 For reducing levels of tumor necrosis factor alpha in mammals; 3-(1-Oxo-4-aminoisoindolin-1-yl)-3-methylpiperidine-2,6 dione; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178400 Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 08/10/2006 | US20060178398 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds |
| 08/10/2006 | US20060178397 1-(3-Methyl-isoquinolin-5-yl)-3-[1-(2-trifluoromethyl-benzyl)pyrrolidin-3-yl]urea; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, algesia, neuralgia, dental pain, headache, migraine, neuropathies, carpal tunnel syndrome, diabetic neuropathy |
| 08/10/2006 | US20060178396 e.g. (3-endo)-3-(2-Hydroxy-2,2-di-2-thienylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide; muscle relaxants, respiratory system disorders; asthma, emphysema, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 08/10/2006 | US20060178395 3-(2-Benzyl-2-hydroxy-3-phenyl-propylidene)-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane iodide; muscle relaxants, respiratory system disorders; asthma, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 08/10/2006 | US20060178394 Inhalable dose of a powder comprising apomorphine or pharmaceutically acceptable salts thereof for therapy of for sexual dysfunction |
| 08/10/2006 | US20060178393 1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 08/10/2006 | US20060178392 CCI-779 polymorph and use thereof |
| 08/10/2006 | US20060178391 Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 08/10/2006 | US20060178390 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| 08/10/2006 | US20060178389 Use of siramesine in the treatment of cancer |
| 08/10/2006 | US20060178388 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 08/10/2006 | US20060178387 Combined treatment with capecitabine and an epidermal growth factor receptor kinase inhibitor |
| 08/10/2006 | US20060178386 For therapy of obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder |
| 08/10/2006 | US20060178385 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents |
| 08/10/2006 | US20060178384 2-(2,6-dimethoxy-phenylamino)-9-methoxy-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one; 3-bromo-N-[3-(9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-ylamino)-phenyl]-benzamide; kinase inhibitor; neutropenia; cytopenia; anemias |
| 08/10/2006 | US20060178383 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) |
| 08/10/2006 | US20060178382 Chinazoline derivatives as aurora kinase inhibitors |
| 08/10/2006 | US20060178381 GlyT-1 inhibitors; CNS disorders such as psychoses, dysfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease; (2-isobutoxy-5-methanesulfonyl-phenyl)-(3-trifluoromethyl-5,7-dihydro-pyrrolo[3,4-b]pyridin-6-yl)-methanone and pyrrolo[3,4-c]pyridines |
| 08/10/2006 | US20060178380 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines |
| 08/10/2006 | US20060178379 Methods of treating patients suffering from movement disorders |
| 08/10/2006 | US20060178378 Novel kinase inhibitors |
| 08/10/2006 | US20060178377 e.g. Ethyl 6-(azidomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxylate; treating diabetes and micro- and macrovascular complications of diabetes, such as retinopathy, neuropathy, and nephropathy |
| 08/10/2006 | US20060178376 Novel process for the preparation of hexacyclic compounds |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178374 Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/10/2006 | US20060178373 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178371 7-amino-pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 08/10/2006 | US20060178370 Ketopiperazine derivatives as bradykinin antagonists |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178368 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
| 08/10/2006 | US20060178367 Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178364 Use of EGFR tyrosinkinase inhibitors for treatment of chronic rhinosinusitis |
| 08/10/2006 | US20060178363 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178361 ATM inhibitors |
| 08/10/2006 | US20060178360 N(2-hydroxyethyl)-4-methoxy-N,2,6-trimethylbenzene- sulphonamide; analgesic, antiinflammatory agent; hyperalgesia and major algesia connected with other pathological conditions such as cancer |
| 08/10/2006 | US20060178359 Tricyclic compound, process for producing the same, and use |
| 08/10/2006 | US20060178358 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 08/10/2006 | US20060178357 Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178355 Analogs of leucascandrolide A |
| 08/10/2006 | US20060178354 Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
| 08/10/2006 | US20060178353 Medicament for preventing and/or treating mammarycarcinoma, containing a steroidal aromatase inhibitor |
| 08/10/2006 | US20060178352 Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
| 08/10/2006 | US20060178351 Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents |